BL-WRIGHT LTD

Company number 13133640 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BL-WRIGHT LTD - Analysis Report

Company Number: 13133640

Analysis Date: 2025-07-20 14:38 UTC

Financial Health Assessment: BL-WRIGHT LTD
As of financial year ending 31 January 2025


1. Financial Health Score: D

Explanation:
The company currently shows a negative net asset position (net liabilities) of £399, which is a critical symptom indicating financial distress. Despite being a micro-entity, the negative working capital and net assets suggest the business is under strain. The absence of employees and minimal current assets (£1) compared to current liabilities (£400) further stress this condition. The negative equity position is a vital warning sign reducing the financial health grade.


2. Key Vital Signs (Core Financial Metrics):

Metric 2025 Value Interpretation
Current Assets £1 Extremely low liquidity; almost no short-term resources.
Current Liabilities £400 Outstanding debts due within one year.
Net Current Assets -£399 Indicates working capital deficiency ("cash flow congestion").
Net Assets (Equity) -£399 Negative shareholder funds, a "symptom of distress" signaling insolvency risk.
Share Capital £1 Very minimal capital base; insufficient buffer.
Employees 0 No workforce, possibly indicating limited operations or start-up phase.

Trend Observation:

  • Net assets have deteriorated from £96 (2023) to -£399 (2025), indicating progressive financial weakening.
  • Current liabilities have increased more than threefold, while current assets have plummeted.

3. Diagnosis: What the Financial Data Reveals

BL-WRIGHT LTD’s financial statements exhibit classic symptoms of a company under financial stress:

  • Negative working capital ("net current liabilities") implies the company does not have enough liquid resources to cover short-term obligations, risking payment defaults.
  • The negative net assets suggest accumulated losses or creditor claims exceeding assets, a serious red flag for solvency.
  • The absence of fixed assets and employees indicates a minimal operational footprint or possibly a dormant-like operational state despite being active.
  • The company is classified as a Micro entity, so limited filing requirements apply, but even within this context, the financial health is poor.
  • The sole director controls 75-100% ownership and has full decision power, which may impact governance and financial decisions.
  • The company has not defaulted on filings, which shows compliance but does not offset financial weakness.

Overall, BL-WRIGHT LTD shows symptoms of financial distress that could worsen without intervention.


4. Recommendations: Specific Actions to Improve Financial Wellness

  1. Improve Liquidity and Working Capital

    • Inject additional capital or secure short-term financing to cover liabilities and create a healthy buffer.
    • Accelerate cash collections or reduce payables where possible.
  2. Operational Review

    • Assess the business model viability given zero employees and minimal assets. Consider restructuring or pivoting operations to generate revenue.
    • Explore cost reduction or outsourcing to minimize fixed costs.
  3. Governance and Oversight

    • The sole director should consider appointing an independent director or advisor to improve oversight and strategic decision-making.
    • Regular financial monitoring and forecasting must be implemented to catch early symptoms of distress.
  4. Stakeholder Communication

    • Communicate openly with creditors regarding payment plans to avoid legal actions.
    • Engage with a financial advisor or insolvency professional if the negative equity trend persists.
  5. Filing and Compliance

    • Continue timely filing of accounts and confirmation statements to maintain regulatory compliance and avoid penalties.

Medical Analogy Summary:
BL-WRIGHT LTD exhibits "signs of systemic financial infection" — negative net assets represent a "weak immune system," and negative working capital is a "circulatory issue" restricting cash flow. Without prompt "treatment" (capital infusion and operational overhaul), the company risks progressing towards insolvency "organ failure."


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.